Functionally-derivatized Nanoantibodies as novel tools for Giardia lamblia cyst detection
PLOS Neglected Tropical Diseases · 09.03.2026 · 20 (3) · e0013844
DOI: 10.1371/journal.pntd.0013844 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 09.03.2026. Verfasst von Corina D Wirdnam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cell Biology, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Giardia lamblia, Giardiasis, Antibodies, Protozoan, Single-Domain Antibodies. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stiftung für wissenschaftliche Forschung an der Universität Zürich, Novartis Stiftung für Medizinisch-Biologische Forschung.
Abstract (Originalsprache)
Giardia lamblia (syn. intestinalis , duodenalis ) is the causative agent of Giardia sis, a diarrheal disease of global medical importance, especially problematic in young children living in unhygienic, resource-constrained settings. Diagnostics of potential Giardia infections are generally done through classic light-microscopy stool examination. This is often insufficient, and ELISA-based fluorescence detection using costly proprietary reagents is employed. These reagents are often not affordable in contexts where they are needed the most, and this limits their use to resource-rich settings where Giardia sis is rarely problematic. To address these issues in medical equity while designing novel strategies to investigate the Giardia cyst wall, we report on the development and characterisation of alpaca derived single-domain antibodies, known as nanoantibodies, elicited against G. lamblia enriched cyst-wall preparations. We evaluated the effectiveness and binding capacity of twelve unique E. coli -produced recombinant nanoantibody sequences for Giardia cyst wall detection and provide proof of concept for the effectiveness and versatility of these protein domains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Cell Biology, University of Bern, Bern, Switzerland.
- Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
- Nanoantibody Service Facility, University of Zurich, Zurich, Switzerland.
- Institute of Parasitology, University of Zurich, Zurich, Switzerland.
- Multidisciplinary Center for Infectious Diseases, University of Bern, Bern, Switzerland.
- Genomics for Health in Africa (GHA), an Africa-Europe Cluster of Research Excellence (CoRE), University of Bern, Bern, Switzerland.
ORCID-Profile: Adrian B Hehl, Carmen Faso
Förderung
- Stiftung für wissenschaftliche Forschung an der Universität Zürich
- Novartis Stiftung für Medizinisch-Biologische Forschung
Zitieren
APA
Wirdnam, C. D., Schaerer, T., Rubin, M., Oberli, A., Štefanić, S., Hehl, A. B., & Faso, C. (2026). Functionally-derivatized Nanoantibodies as novel tools for Giardia lamblia cyst detection. PLOS Neglected Tropical Diseases, 20(3), e0013844. https://doi.org/10.1371/journal.pntd.0013844
Vancouver
Wirdnam CD, Schaerer T, Rubin M, Oberli A, Štefanić S, Hehl AB, et al. Functionally-derivatized Nanoantibodies as novel tools for Giardia lamblia cyst detection. PLOS Neglected Tropical Diseases. 2026;20(3):e0013844. doi:10.1371/journal.pntd.0013844
BibTeX
@article{Wirdnam2026,
author = {Wirdnam, Corina D and Schaerer, Timothé and Rubin, Matthias and Oberli, Alexander and Štefanić, Saša and Hehl, Adrian B and Faso, Carmen},
title = {Functionally-derivatized Nanoantibodies as novel tools for Giardia lamblia cyst detection},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
volume = {20},
number = {3},
pages = {e0013844},
doi = {10.1371/journal.pntd.0013844}
}
EUVIMED